Skip to main content
Top
Published in: Abdominal Radiology 5/2017

01-05-2017

Abdominal seeding of renal cell carcinoma: radiologic, pathologic, and prognostic features

Authors: Seung Hyun Park, Young Taik Oh, Dae Chul Jung, Nam Hoon Cho, Young Deuk Choi, Sung Yoon Park

Published in: Abdominal Radiology | Issue 5/2017

Login to get access

Abstract

Purpose

We analyzed radiologic and histologic characteristics, and prognosis of abdominal seeding from renal cell carcinoma (RCC).

Methods

Consecutive 25 patients with RCC and histologically or radiologically diagnosed abdominal seeding were analyzed. No patient had another type of malignancy. Histologic subtype, Fuhrman grade, sarcomatoid differentiation, and T-stage of primary tumors were assessed. Pre- or postoperative presentation of seeding was investigated. Median survival time and RCC-specific survival rates were evaluated.

Results

Of 25 patients, 15 (60%) died and 4 (16%) were hopelessly discharged (median follow-up time, 6 months; range 1–62 months). Histologic subtypes were clear cell (76%, 19/25), papillary (16%, 4/25), chromophobe (4%, 1/25), and poorly differentiated (4%, 1/25). Fuhrman grades were 4 (48%, 12/25), 3 (36%, 9/25), 2 (12%, 3/25), and unknown (4%, 1/25). T-stage of the four patients with grade 2 or unknown was 3a. Sarcomatoid differentiation and postoperative occurrence were found in 32% (8/25) and 80% (20/25), respectively. Median survival time was 13 months, and 1-year, 2-year, and 3-year RCC-specific survival rates were 51%, 41%, and 31%, respectively.

Conclusion

Abdominal seeding may occur in various subtypes of RCC with high Fuhrman grade including sarcomatoid differentiation or high T-stage, and appears to be related to poor prognosis.
Literature
1.
go back to reference Ljungberg B, Bensalah K, Canfield S, et al. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924CrossRef Ljungberg B, Bensalah K, Canfield S, et al. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924CrossRef
2.
go back to reference Thompson RH, Atwell T, Schmit G, et al. (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2):252–259CrossRef Thompson RH, Atwell T, Schmit G, et al. (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2):252–259CrossRef
3.
go back to reference Flanigan RC, Mickisch G, Sylvester R, et al. (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171(3):1071–1076CrossRef Flanigan RC, Mickisch G, Sylvester R, et al. (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171(3):1071–1076CrossRef
4.
go back to reference Heng DY, Wells JC, Rini BI, et al. (2014) Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 66(4):704–710CrossRef Heng DY, Wells JC, Rini BI, et al. (2014) Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 66(4):704–710CrossRef
5.
go back to reference Dabestani S, Marconi L, Hofmann F, et al. (2014) Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 15(12):e549–561CrossRef Dabestani S, Marconi L, Hofmann F, et al. (2014) Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 15(12):e549–561CrossRef
6.
go back to reference Ko JJ, Xie W, Kroeger N, et al. (2015) The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol 16(3):293–300CrossRef Ko JJ, Xie W, Kroeger N, et al. (2015) The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol 16(3):293–300CrossRef
7.
go back to reference Bianchi M, Sun M, Jeldres C, et al. (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980CrossRef Bianchi M, Sun M, Jeldres C, et al. (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980CrossRef
8.
go back to reference Weiss L, Harlos JP, Torhorst J, et al. (1988) Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 114(6):605–612CrossRef Weiss L, Harlos JP, Torhorst J, et al. (1988) Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 114(6):605–612CrossRef
9.
go back to reference Bush WH Jr, Burnett LL, Gibbons RP (1977) Needle tract seeding of renal cell carcinoma. AJR Am J Roentgenol 129(4):725–727CrossRef Bush WH Jr, Burnett LL, Gibbons RP (1977) Needle tract seeding of renal cell carcinoma. AJR Am J Roentgenol 129(4):725–727CrossRef
10.
go back to reference Tartar VM, Heiken JP, McClennan BL (1991) Renal cell carcinoma presenting with diffuse peritoneal metastases: CT findings. J Comput Assist Tomogr 15(3):450–453CrossRef Tartar VM, Heiken JP, McClennan BL (1991) Renal cell carcinoma presenting with diffuse peritoneal metastases: CT findings. J Comput Assist Tomogr 15(3):450–453CrossRef
11.
go back to reference Stavropoulos NJ, Deliveliotis C, Kouroupakis D, et al. (1995) Renal cell carcinoma presenting as a large abdominal mass with an extensive peritoneal metastasis. Urol Int 54(3):169–170CrossRef Stavropoulos NJ, Deliveliotis C, Kouroupakis D, et al. (1995) Renal cell carcinoma presenting as a large abdominal mass with an extensive peritoneal metastasis. Urol Int 54(3):169–170CrossRef
12.
go back to reference Chen P, Middlebrook MR, Goldman SM, et al. (1998) Sister Mary Joseph nodule from metastatic renal cell carcinoma. J Comput Assist Tomogr 22(5):756–757CrossRef Chen P, Middlebrook MR, Goldman SM, et al. (1998) Sister Mary Joseph nodule from metastatic renal cell carcinoma. J Comput Assist Tomogr 22(5):756–757CrossRef
13.
go back to reference Akhavein A, Neuberger MM, Dahm P (2012) Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma. BMJ Case Rep 2012:bcr2012006948CrossRef Akhavein A, Neuberger MM, Dahm P (2012) Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma. BMJ Case Rep 2012:bcr2012006948CrossRef
14.
go back to reference Esnakula AK, Naab TJ, Green W, et al. (2013) Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation. BMJ Case Rep 2013:bcr2013008725PubMedPubMedCentral Esnakula AK, Naab TJ, Green W, et al. (2013) Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation. BMJ Case Rep 2013:bcr2013008725PubMedPubMedCentral
15.
go back to reference Mullins JK, Rodriguez R (2013) Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J 7(3–4):E176–179CrossRef Mullins JK, Rodriguez R (2013) Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J 7(3–4):E176–179CrossRef
16.
go back to reference Ploumidis A, Panoskaltsis T, Gavresea T, et al. (2013) Tumor seeding incidentally found two years after robotic-Assisted radical nephrectomy for papillary renal cell carcinoma. A case report and review of the literature. Int J Surg Case Rep 4(6):561–564CrossRef Ploumidis A, Panoskaltsis T, Gavresea T, et al. (2013) Tumor seeding incidentally found two years after robotic-Assisted radical nephrectomy for papillary renal cell carcinoma. A case report and review of the literature. Int J Surg Case Rep 4(6):561–564CrossRef
17.
go back to reference Sainani NI, Tatli S, Anthony SG, et al. (2013) Successful percutaneous radiologic management of renal cell carcinoma tumor seeding caused by percutaneous biopsy performed before ablation. J Vasc Interv Radiol 24(9):1404–1408CrossRef Sainani NI, Tatli S, Anthony SG, et al. (2013) Successful percutaneous radiologic management of renal cell carcinoma tumor seeding caused by percutaneous biopsy performed before ablation. J Vasc Interv Radiol 24(9):1404–1408CrossRef
18.
go back to reference Giorgadze T, Qureshi F, Jacques SM, et al. (2013) Retroperitoneal recurrence of a stage 1 renal cell carcinoma 4 years following core biopsy and fine needle aspiration: possible needle tract seeding. Diagn Cytopathol 41(5):474CrossRef Giorgadze T, Qureshi F, Jacques SM, et al. (2013) Retroperitoneal recurrence of a stage 1 renal cell carcinoma 4 years following core biopsy and fine needle aspiration: possible needle tract seeding. Diagn Cytopathol 41(5):474CrossRef
19.
go back to reference Goncalves MO, Benidir T, Erbano BO, et al. (2014) Peritoneal metastases from renal cell carcinoma: Images in urology. Can Urol Assoc J 8(5–6):E391–392CrossRef Goncalves MO, Benidir T, Erbano BO, et al. (2014) Peritoneal metastases from renal cell carcinoma: Images in urology. Can Urol Assoc J 8(5–6):E391–392CrossRef
20.
go back to reference Win AZ, Aparici CM (2014) Omental nodular deposits of recurrent chromophobe renal cell carcinoma seen on FDG-PET/CT. J Clin Imaging Sci 4:51CrossRef Win AZ, Aparici CM (2014) Omental nodular deposits of recurrent chromophobe renal cell carcinoma seen on FDG-PET/CT. J Clin Imaging Sci 4:51CrossRef
21.
go back to reference Pilanci KN, Ordu C, Akpinar H, et al. (2014) Dramatic Response to Catumaxomab Treatment for Malign Ascites Related to Renal Cell Carcinoma With Sarcomatoid Differentiation. Am J Ther Pilanci KN, Ordu C, Akpinar H, et al. (2014) Dramatic Response to Catumaxomab Treatment for Malign Ascites Related to Renal Cell Carcinoma With Sarcomatoid Differentiation. Am J Ther
22.
go back to reference Chang DT, Sur H, Lozinskiy M, et al. (2015) Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol 56(9):666–669CrossRef Chang DT, Sur H, Lozinskiy M, et al. (2015) Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol 56(9):666–669CrossRef
23.
go back to reference Soares D, Ahmadi N, Crainic O, et al. (2015) Papillary renal cell carcinoma seeding along a percutaneous biopsy tract. Case Rep Urol 2015:925254PubMedPubMedCentral Soares D, Ahmadi N, Crainic O, et al. (2015) Papillary renal cell carcinoma seeding along a percutaneous biopsy tract. Case Rep Urol 2015:925254PubMedPubMedCentral
24.
go back to reference Yuksel OH, Yildirim C, Urkmez A, et al. (2015) Contralateral tumor seeding of renal cell carcinoma mimicking late metastasis of liver after laparoscopic nephrectomy: A case report with review of the literature. Arch Ital Urol Androl 87(3):256–257CrossRef Yuksel OH, Yildirim C, Urkmez A, et al. (2015) Contralateral tumor seeding of renal cell carcinoma mimicking late metastasis of liver after laparoscopic nephrectomy: A case report with review of the literature. Arch Ital Urol Androl 87(3):256–257CrossRef
25.
go back to reference Brufau BP, Cerqueda CS, Villalba LB, et al. (2013) Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics 33(6):1691–1716CrossRef Brufau BP, Cerqueda CS, Villalba LB, et al. (2013) Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics 33(6):1691–1716CrossRef
26.
go back to reference Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs PET/CT. Abdom Imaging 33(1):87–93CrossRef Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs PET/CT. Abdom Imaging 33(1):87–93CrossRef
27.
go back to reference Cheville JC, Lohse CM, Zincke H, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRef Cheville JC, Lohse CM, Zincke H, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRef
28.
go back to reference Shuch B, Amin A, Armstrong AJ, et al. (2015) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 67(1):85–97CrossRef Shuch B, Amin A, Armstrong AJ, et al. (2015) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 67(1):85–97CrossRef
29.
go back to reference Delahunt B, Cheville JC, Martignoni G, et al. (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37(10):1490–1504CrossRef Delahunt B, Cheville JC, Martignoni G, et al. (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37(10):1490–1504CrossRef
30.
go back to reference Shinagare AB, Vikram R, Jaffe C, et al. (2015) Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40(6):1684–1692CrossRef Shinagare AB, Vikram R, Jaffe C, et al. (2015) Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40(6):1684–1692CrossRef
31.
go back to reference Khor LY, Dhakal HP, Jia X, et al. (2016) Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol 40(9):1224–1231CrossRef Khor LY, Dhakal HP, Jia X, et al. (2016) Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol 40(9):1224–1231CrossRef
32.
go back to reference Jamshidi N, Jonasch E, Zapala M, et al. (2015) The radiogenomic risk score: construction of a prognostic quantitative, noninvasive image-based molecular assay for renal cell carcinoma. Radiology 277(1):114–123CrossRef Jamshidi N, Jonasch E, Zapala M, et al. (2015) The radiogenomic risk score: construction of a prognostic quantitative, noninvasive image-based molecular assay for renal cell carcinoma. Radiology 277(1):114–123CrossRef
33.
go back to reference Eggener SE, Yossepowitch O, Pettus JA, et al. (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24(19):3101–3106CrossRef Eggener SE, Yossepowitch O, Pettus JA, et al. (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24(19):3101–3106CrossRef
34.
go back to reference Naito S, Yamamoto N, Takayama T, et al. (2010) Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol 57(2):317–325CrossRef Naito S, Yamamoto N, Takayama T, et al. (2010) Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol 57(2):317–325CrossRef
Metadata
Title
Abdominal seeding of renal cell carcinoma: radiologic, pathologic, and prognostic features
Authors
Seung Hyun Park
Young Taik Oh
Dae Chul Jung
Nam Hoon Cho
Young Deuk Choi
Sung Yoon Park
Publication date
01-05-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-1029-8

Other articles of this Issue 5/2017

Abdominal Radiology 5/2017 Go to the issue

Classics in Abdominal Imaging

The “O” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.